Dr Steven Rosenberg’s group reported isolation of KRASG12D specific TCR from CRC patients which was HLA-C*0802 restricted (41), but HLA-C*0802 restricted TCR is not that of valuable for further development because of low frequency of HLA-C*0802 in most countries. This evidence concerns the gene HLA-C and colorectal carcinoma.